CTOR vs LVS · $105.2M cap vs P/E 28, rev $2.90B
Citius Oncology, Inc. (CTOR) versus Las Vegas Sands Corp (LVS) — a side-by-side from cached financials, not a winner call.
Citius Oncology, Inc. (CTOR) is a drug manufacturers - specialty & generic company listed on US.
Las Vegas Sands Corp (LVS) is a resorts & casinos company listed on US.
CTOR does not have a complete income-statement cache yet.
Latest reported LVS revenue for 2024-12-31 was $2.90B. Net income was $392.0M. Revenue was up 8.0% from 2024-09-30 to 2024-12-31. LVS currently screens at market cap $35.70B and trailing P/E 28.3.
CTOR currently screens at market cap $105.2M. LVS currently screens at market cap $35.70B and trailing P/E 28.3.
Not investment advice. Open the CTOR and LVS stock pages for the full models.
Not investment advice.